ASP Isotopes completes construction phase of Ytterbium-176 enrichment facility

ASP Isotopes, an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, announced advances in its construction program and the hiring of key staff…”Currently, there exist significant supply-side challenges for many essential radioisotopes used in various oncology treatments. We have received a considerable amount of interest from customers in North America, Europe and Asia for Ytterbium-176 and we look forward to easing supply chains and improving the quality of life of thousands of patients every year”, said Paul Mann, ASP Isotopes’s Chairman and CEO…The Company is evaluating the potential opportunity to construct an advanced nuclear fuel plant in the United Kingdom, which would likely result in the inward investment of hundreds of millions of dollars from Quantum Leap Energy LLC and its partners and customers. The advanced nuclear fuel plant would likely create hundreds of permanent jobs in the United Kingdom. ASP Isotopes has previously announced that it has entered into two MOUs with U.S.-based Small Modular Reactor SMR companies that contemplate the SMR companies making capital investments into the development of high-assay low-enriched uranium HALEU enrichment facilities. Potential customers, with whom ASP Isotopes has been in discussions, have indicated their requirements of over $37B of HALEU by 2037